Shares of Biogen Inc. BIIB shed 3.41% to $150.03 Friday, on what proved to be an all-around mixed trading session for the ...
This summary covers key developments in health news, including Mitsubishi Pharma's bidding war, legal actions involving J&J ...
In a rare move, the U.S. agency behind Medicare is warning Medicare Advantage providers they can’t have blanket policies that ...
Investors in some of the S&P 500’s worst performers may be on the verge of a so-called dead-cat bounce. History shows stocks ...